What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

SGMC Health has welcomed Daniel Sohinki, MD, a board-certified cardiac electrophysiologist, to its expanding team of ...

New research finds that a key compound in rosemary may help treat Alzheimer’s disease. Here, experts explain the link between rosemary and brain health.

We are moving from treating inherited diseases after birth to preventing them at the start of life.

Gene delivery systems can target specific brain cells, a breakthrough that could lead to treatments for Parkinson's, Alzheimer's and other neurodegenerative diseases.

Scientists have developed new tools to improve gene therapy in advanced stages of inherited retinal diseases (IRDs) such as retinitis pigmentosa and Leber congenital amaurosis.

Robert F. Kennedy Jr.'s plan is more than just another comment in a series of diatribes. It is an alarming expansion of the medicalization and surveillance of autistic people.

New research shows that semaglutide, the compound in the weight-loss drug Wegovy, could treat an increasingly common liver disease.

We need to understand that substance use disorder is a medical condition like any other and provide proper, compassionate care.

The problem with studying GLP-1s in Parkinson’s disease, Dr. Standaert said, is that what exenatide is supposed to be doing in the brain is not clear.

Profile The positions in the table below reflect the William Osler Health System's position overall, domestically, within their sector, and in various subject areas based on their Share. Each ...

Introduction: Evolocumab and other monoclonal antibodies against PCSK9 reduced major adverse CV outcomes in clinical trials of patients with CV disease treated up to a median of 2.8 years. OSLER-1 ...